시장보고서

상품코드

1762332

세계의 외용제 CDMO 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 제제별, 서비스별, 최종 용도별, 지역별, 예측(2025-2034년)

Topical Drugs CDMO Market Size, Share, Trends, & Industry Analysis Report By Formulation (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), Service, End Use, By Region - Market Forecast, 2025-2034

발행일: 2025년 06월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 130 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 외용제 CDMO 시장 세계 시장 규모는 2034년까지 1,254억 2,000만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 향후 시장 성장에 대한 분석을 제공합니다.

외용제 CDMO 시장은 피부나 점막에 직접 적용하도록 설계된 의약품의 개발, 제형화, 생산을 위한 종합적인 서비스를 제공하는 전문 기업을 의미합니다. 이러한 서비스는 초기 연구개발부터 상업용 제품의 대규모 생산에 이르기까지 외용제 의약품의 전체 라이프사이클에 걸쳐 있습니다. 기본적으로 CDMO는 제약회사와 바이오 제약회사의 중요한 파트너로서 다양한 외용제를 효율적으로, 엄격한 규제 기준에 따라 시장에 출시할 수 있도록 도와줍니다.

습진, 건선, 여드름 등 다양한 피부 질환의 전 세계 확산으로 인해 혁신적인 외용제 치료에 대한 수요가 증가하고 있습니다. 이에 따라 제약사들은 점막용 의약품을 포함한 복잡한 외용제의 제형 및 제조에 대한 전문성을 갖춘 CDMO에 의존하고 있습니다. 또한, 비용 효율성과 유연한 제조 능력의 필요성에 따라 제약업계의 아웃소싱 트렌드가 증가함에 따라 외용제 CDMO 서비스에 대한 수요가 더욱 증가하고 있습니다.

외용제 CDMO 시장 보고서 하이라이트

제형별로는 반고체 제제 분야가 피부과, 통증 관리, 항감염제 등 다양한 치료 영역에서 널리 사용되면서 2024년 가장 큰 점유율을 차지했습니다.

서비스별로는 수탁 제조 부문이 2024년 시장을 주도했습니다. 제약사들이 전문 지식 활용, 운영 비용 절감, 확장 가능한 제조 능력의 이점을 얻기 위해 외용제의 실제 제조를 아웃소싱하는 사례가 증가하고 있기 때문입니다.

최종 용도별로는 제약사들이 일반의약품부터 전문의약품까지 다양한 외용제 포트폴리오를 지속적으로 개발 및 상용화하면서 2024년 제약사 부문이 가장 큰 점유율을 차지했습니다.

지역별로는 아시아태평양이 2024년 외용제 CDMO 시장에서 가장 큰 점유율을 차지했습니다. 이는 주로 제조의 비용 효율성, 의료 인프라의 확장, 중국 및 인도와 같은 국가의 제약 산업의 성장이 외용제 제조의 세계 아웃소싱을 위한 매력적인 거점이 되었기 때문입니다.

이 시장의 주요 기업으로는 Lubrizol Corporation(Lubrizol Life Science), Cambrex Corporation, Lonza Group AG, Catalent Inc. Piramal Pharma Solutions, PCI Pharma Services, MedPharm Ltd, Tergus Pharma, Contract Pharmaceuticals Limited 등이 있습니다.

주요 조사 결과
서론
- 외용제 CDMO 시장 분석 : 지역별, 2020년-2034년
북미
- 북미 : 제제별, 2020-2034년
- 북미 : 서비스별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 미국
- 캐나다
유럽
- 유럽 : 제제별, 2020-2034년
- 유럽 : 서비스별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 제제별, 2020-2034년
- 아시아태평양 : 서비스별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 제제별, 2020-2034년
- 중동 및 아프리카 : 서비스별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 제제별, 2020-2034년
- 라틴아메리카 : 서비스별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제9장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제10장 기업 개요

Cambrex Corporation
Catalent Inc.
Contract Pharmaceuticals Limited
MedPharm Ltd.
PCI Pharma Services
Pierre Fabre S.A.
Piramal Pharma Solutions
Recipharm AB
Tergus Pharma
The Lubrizol Corporation(Lubrizol Life Science)

LSH 25.07.10

The topical drugs cdmo market global market size is expected to reach USD 125.42 billion by 2034, according to a new study by Polaris Market Research. The report "Topical Drugs CDMO Market Size, Share, Trends, & Industry Analysis Report By Formulation (Semi-solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), By Service, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The topical drugs CDMO market refers to specialized companies that provide comprehensive services for the development, formulation, and production of pharmaceutical products designed to be applied directly to the skin or mucous membranes. These services span the entire lifecycle of a topical drug, from initial research and development to the large-scale manufacturing of commercial products. Essentially, CDMOs act as crucial partners for pharmaceutical and biopharmaceutical companies, helping them bring a wide array of topical medications to market efficiently and in compliance with strict regulatory standards.

The increasing global prevalence of various skin conditions, such as eczema, psoriasis, and acne, fuels the demand for innovative topical treatments. This, in turn, leads pharmaceutical companies to rely on CDMOs for their specialized expertise in formulating and producing complex topical medications, including mucosal drugs. Additionally, the growing trend of outsourcing within the pharmaceutical industry, driven by cost-efficiency and the need for flexible manufacturing capabilities, further boosts the demand for topical drugs CDMO services.

Topical Drugs CDMO Market Report Highlights

By formulation, the semi-solid formulations segment held the largest share in 2024 due to their widespread use across various therapeutic areas such as dermatology, pain management, and anti-infectives.

Based on service, the contract manufacturing segment dominated the market in 2024, as pharmaceutical companies increasingly outsource the actual production of their topical drugs to leverage specialized expertise, reduce operational costs, and benefit from scalable manufacturing capabilities.

By end use, the pharmaceutical companies segment held the largest share in 2024 as they consistently develop and commercialize a broad portfolio of topical drugs, from over-the-counter to prescription medications.

By region, Asia Pacific held the largest share of the topical drugs CDMO market in 2024. This is primarily attributed to cost-effectiveness in manufacturing, expanding healthcare infrastructure, and growing pharmaceutical industries in countries such as China and India, making it an attractive hub for global outsourcing of topical drug production.

A few key players in the market include The Lubrizol Corporation (Lubrizol Life Science), Cambrex Corporation, Lonza Group AG, Catalent Inc., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, PCI Pharma Services, MedPharm Ltd., Tergus Pharma, and Contract Pharmaceuticals Limited.

Polaris Market Research has segmented the topical drugs CDMO market report based on formulation, service, end use, and region:

By Formulation Outlook (Revenue - USD Billion, 2020-2034)

Semi-solid Formulations

Creams

Ointments

Gel

Others

Liquid Formulations

Solid Formulations

Transdermal Products

By Service Outlook (Revenue - USD Billion, 2020-2034)

Contract Development

Contract Manufacturing

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Pharmaceutical Companies

Biopharmaceutical Companies

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Topical Drugs CDMO Market Insights

4.1. Topical Drugs CDMO Market - Market Snapshot
4.2. Topical Drugs CDMO Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Prevalence of Skin Conditions
  - 4.2.1.2. Growing Trend of Pharmaceutical Outsourcing
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Regulatory Complexity and Stringency
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Topical Drugs CDMO Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Topical Drugs CDMO Market, by Formulation

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
5.3. Semi-solid Formulations
- 5.3.1. Global Topical Drugs CDMO Market, by Semi-solid Formulations, by Region, 2020-2034 (USD Billion)
5.4. Liquid Formulations
- 5.4.1. Global Topical Drugs CDMO Market, by Liquid Formulations, by Region, 2020-2034 (USD Billion)
5.5. Solid Formulations
- 5.5.1. Global Topical Drugs CDMO Market, by Solid Formulations, by Region, 2020-2034 (USD Billion)
5.6. Transdermal Products
- 5.6.1. Global Topical Drugs CDMO Market, by Transdermal Products, by Region, 2020-2034 (USD Billion)

6. Global Topical Drugs CDMO Market, by Service

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
6.3. Contract Development
- 6.3.1. Global Topical Drugs CDMO Market, by Contract Development, by Region, 2020-2034 (USD Billion)
6.4. Contract Manufacturing
- 6.4.1. Global Topical Drugs CDMO Market, by Contract Manufacturing, by Region, 2020-2034 (USD Billion)

7. Global Topical Drugs CDMO Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
7.3. Pharmaceutical Companies
- 7.3.1. Global Topical Drugs CDMO Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
7.4. Biopharmaceutical Companies
- 7.4.1. Global Topical Drugs CDMO Market, by Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
7.5. Others
- 7.5.1. Global Topical Drugs CDMO Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Topical Drugs CDMO Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Topical Drugs CDMO Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Topical Drugs CDMO Market - North America
- 8.3.1. North America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.3.2. North America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.3.3. North America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. Topical Drugs CDMO Market - U.S.
  - 8.3.4.1. U.S.: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. Topical Drugs CDMO Market - Canada
  - 8.3.5.1. Canada: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
8.4. Topical Drugs CDMO Market - Europe
- 8.4.1. Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.2. Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.4.3. Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. Topical Drugs CDMO Market - UK
  - 8.4.4.1. UK: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. Topical Drugs CDMO Market - France
  - 8.4.5.1. France: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. Topical Drugs CDMO Market - Germany
  - 8.4.6.1. Germany: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. Topical Drugs CDMO Market - Italy
  - 8.4.7.1. Italy: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. Topical Drugs CDMO Market - Spain
  - 8.4.8.1. Spain: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. Topical Drugs CDMO Market - Netherlands
  - 8.4.9.1. Netherlands: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. Topical Drugs CDMO Market - Russia
  - 8.4.10.1. Russia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. Topical Drugs CDMO Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
8.5. Topical Drugs CDMO Market - Asia Pacific
- 8.5.1. Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. Topical Drugs CDMO Market - China
  - 8.5.4.1. China: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. Topical Drugs CDMO Market - India
  - 8.5.5.1. India: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. Topical Drugs CDMO Market - Malaysia
  - 8.5.6.1. Malaysia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. Topical Drugs CDMO Market - Japan
  - 8.5.7.1. Japan: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. Topical Drugs CDMO Market - Indonesia
  - 8.5.8.1. Indonesia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. Topical Drugs CDMO Market - South Korea
  - 8.5.9.1. South Korea: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. Topical Drugs CDMO Market - Australia
  - 8.5.10.1. Australia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. Topical Drugs CDMO Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
8.6. Topical Drugs CDMO Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. Topical Drugs CDMO Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. Topical Drugs CDMO Market - UAE
  - 8.6.5.1. UAE: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. Topical Drugs CDMO Market - Israel
  - 8.6.6.1. Israel: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. Topical Drugs CDMO Market - South Africa
  - 8.6.7.1. South Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. Topical Drugs CDMO Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
8.7. Topical Drugs CDMO Market - Latin America
- 8.7.1. Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. Topical Drugs CDMO Market - Mexico
  - 8.7.4.1. Mexico: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. Topical Drugs CDMO Market - Brazil
  - 8.7.5.1. Brazil: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. Topical Drugs CDMO Market - Argentina
  - 8.7.6.1. Argentina: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. Topical Drugs CDMO Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Cambrex Corporation
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Catalent Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Contract Pharmaceuticals Limited
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. MedPharm Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. PCI Pharma Services
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Pierre Fabre S.A.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Piramal Pharma Solutions
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Recipharm AB
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Tergus Pharma
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. The Lubrizol Corporation (Lubrizol Life Science)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development

세계의 외용제 CDMO 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 제제별, 서비스별, 최종 용도별, 지역별, 예측(2025-2034년)

Topical Drugs CDMO Market Size, Share, Trends, & Industry Analysis Report By Formulation (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), Service, End Use, By Region - Market Forecast, 2025-2034

외용제 CDMO 시장 보고서 하이라이트

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 외용제 CDMO 시장 인사이트

제5장 세계의 외용제 CDMO 시장 : 제제별

제6장 세계의 외용제 CDMO 시장 : 서비스별

제7장 세계의 외용제 CDMO 시장 : 최종 용도별

제8장 세계의 외용제 CDMO 시장 : 지역별